Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
Purpose Fluorouracil (FU)-leucovorin (LV), irinotecan, and oxaliplatin administered alone or
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey, D Sargent… - Journal of Clinical …, 2004 - ohiostate.elsevierpure.com
Purpose: Fluorouracil (FU)-leucovorin (LV), irinotecan, and oxaliplatin administered alone or
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
[引用][C] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A GROTHEY, D SARGENT… - Journal of clinical …, 2004 - pascal-francis.inist.fr
Survival of patients with advanced colorectal cancer improves with the availability of
fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment CNRS Inist …
fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment CNRS Inist …
Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment
A Grothey, D Sargent, RM Goldberg… - Journal of Clinical …, 2004 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Fluorouracil (FU)-leucovorin (LV),
irinotecan, and oxaliplatin administered alone or in combination have proven effective in the …
irinotecan, and oxaliplatin administered alone or in combination have proven effective in the …
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey, D Sargent… - Journal of Clinical …, 2004 - mayoclinic.elsevierpure.com
Purpose: Fluorouracil (FU)-leucovorin (LV), irinotecan, and oxaliplatin administered alone or
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.
A Grothey, D Sargent, RM Goldberg… - Journal of Clinical …, 2004 - europepmc.org
Purpose Fluorouracil (FU)-leucovorin (LV), irinotecan, and oxaliplatin administered alone or
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey, D Sargent… - Journal of clinical …, 2004 - pubmed.ncbi.nlm.nih.gov
Purpose Fluorouracil (FU)-leucovorin (LV), irinotecan, and oxaliplatin administered alone or
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
in combination have proven effective in the treatment of advanced colorectal cancer (CRC) …
[引用][C] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A GROTHEY - J Clin Oncol, 2004 - cir.nii.ac.jp
Survival of patients with advanced colorectal cancer improves with the availability of
fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment | CiNii Research …
fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment | CiNii Research …